Profilo
Christopher Sweeney is Medical Director of Semafore Pharmaceuticals, Inc. and Clinical Director of the Developmental Therapeutics Program for the Division of Hematology and Oncology of the IU Medical School Cancer Center.
He was an Internal Medicine Resident of the Gundersen Lutheran Medical Center from 1994 to 1997 and a Fellow in Hematology and Oncology of the Indiana University Medical Center from 1997 to 2000.
He received an MD from the University of Adelaide in 1992.
Precedenti posizioni note di Christopher Sweeney
| Società | Posizione | Fine |
|---|---|---|
Semafore Pharmaceuticals, Inc.
 Semafore Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Semafore Pharmaceuticals, Inc. develops and discovers drugs for multiple disorders including cancer. The company was founded by Christopher J. Garlich and Ronald Michal in 2000 and is headquartered in Indianapolis, IN. | Corporate Officer/Principal | - |
Formazione di Christopher Sweeney
| University of Adelaide | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 1 |
|---|---|
Semafore Pharmaceuticals, Inc.
Semafore Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Semafore Pharmaceuticals, Inc. develops and discovers drugs for multiple disorders including cancer. The company was founded by Christopher J. Garlich and Ronald Michal in 2000 and is headquartered in Indianapolis, IN. | Retail Trade |
- Borsa valori
- Insiders
- Christopher Sweeney
